Insider · CIK 0001295913

Saad Mark E

Reports to the SEC for 3 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001295913

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-08	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1,429 sh	—	—	11,431
2026-06-08	AXSMAxsome Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−1,429 sh	—	—	0
2026-06-05	AXSMAxsome Therapeutics, Inc. · Restricted Stock UnitsA Award	Director	AAward	+1,721 sh	—	—	1,721
2025-12-31	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+6,231 sh	$8.02	+$50K	16,233
2025-12-31	AXSMAxsome Therapeutics, Inc.S Sale	Director	SSale	−6,231 sh	$165.18	−$1.03M	10,002
2025-12-31	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+31.3K sh	$4.95	+$155K	41,348
2025-12-31	AXSMAxsome Therapeutics, Inc.S Sale	Director	SSale	−31.3K sh	$165.18	−$5.18M	10,002
2025-12-31	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−6,231 sh	—	—	0
2025-12-31	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−31.3K sh	—	—	0
2025-09-05	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+9,127 sh	$9.00	+$82.1K	19,129
2025-09-05	AXSMAxsome Therapeutics, Inc.S Sale	Director	SSale	−9,127 sh	$125.07	−$1.14M	10,002
2025-09-05	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−9,127 sh	—	—	0
2025-06-06	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+3,166 sh	—	—	3,166
2025-06-06	AXSMAxsome Therapeutics, Inc. · Restricted Stock UnitsA Award	Director	AAward	+1,429 sh	—	—	1,429
2025-02-21	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+1,494 sh	—	—	1,494
2024-09-11	AXSMAxsome Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+11K sh	$3.67	+$40.4K	21,018
2024-09-11	AXSMAxsome Therapeutics, Inc.S Sale	Director	SSale	−11K sh	$91.31	−$1.01M	10,002
2024-09-11	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−11K sh	—	—	0
2024-06-07	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+5,799 sh	—	—	5,799
2024-02-27	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+1,519 sh	—	—	1,519
2023-06-02	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+5,681 sh	—	—	5,681
2023-03-02	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+2,224 sh	—	—	2,224
2022-06-03	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17K sh	—	—	16,976
2022-03-04	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+2,337 sh	—	—	2,337
2021-11-17	AXSMAxsome Therapeutics, Inc.P Purchase	Director	PPurchase	+3,000 sh	$34.53	+$104K	10,002
2021-11-17	AXSMAxsome Therapeutics, Inc.P Purchase	Director	PPurchase	+100 sh	$34.40	+$3,439.5	100
2021-11-17	AXSMAxsome Therapeutics, Inc.P Purchase	Director	PPurchase	+100 sh	$34.45	+$3,445	100
2021-11-17	AXSMAxsome Therapeutics, Inc.P Purchase	Director	PPurchase	+100 sh	$34.40	+$3,440	100
2021-06-04	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+7,325 sh	—	—	7,325
2021-03-05	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+1,241 sh	—	—	1,241
2021-01-05	VJETFlyte Aviation, Inc.A Award	Director	AAward	+8,227 sh	—	—	13,750
2020-10-12	VJETFlyte Aviation, Inc.A Award	Director	AAward	+100K sh	—	—	138,085
2020-06-05	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+13K sh	—	—	13,000
2020-03-17	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+3,789 sh	—	—	3,789
2020-01-06	VJETFlyte Aviation, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+49.6K sh	—	—	49,576
2019-06-07	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+13K sh	—	—	13,000
2019-06-06	VJETFlyte Aviation, Inc.A Award	Director	AAward	+29.9K sh	—	—	38,085
2019-05-23	AXSMAxsome Therapeutics, Inc.P Purchase	Director	PPurchase	+3,500 sh	$22.33	+$78.2K	7,002
2019-03-19	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+29.4K sh	—	—	29,387
2018-10-04	VJETFlyte Aviation, Inc.A Award	Director	AAward	+8,235 sh	—	—	8,235
2018-06-01	AXSMAxsome Therapeutics, Inc. · Stock Options (right to buy)A Award	Director	AAward	+13K sh	—	—	13,000
2018-03-12	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+32.6K sh	—	—	32,602
2017-03-15	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+31.3K sh	—	—	31,346
2017-03-15	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+11K sh	—	—	11,000
2016-05-27	AXSMAxsome Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+6,231 sh	—	—	6,231
2015-11-24	AXSMAxsome Therapeutics, Inc.C Conversion	Director	CConversion	+3,502 sh	$5.94	+$20.8K	3,502
2015-11-24	AXSMAxsome Therapeutics, Inc. · 8% Convertible NoteA Award	Director	AAward	+3,502 sh	—	—	0
2015-11-19	AXSMAxsome Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Director	AAward	+9,127 sh	—	—	9,127
2013-01-31	CNSYCERENOME, INC.D Disposition to Issuer	Chief Financial Officer	DDisposition to Issuer	−14.1K sh	—	—	138,430
2013-01-31	CNSYCERENOME, INC. · Employee Stock OptionA Award	Chief Financial Officer	AAward	+150K sh	—	—	845,000

Recent filings

Accepted (ET)
Jun 104
Saad Mark E0001193125-26-266436
SEC(opens sec.gov)
Jun 94
Saad Mark E0001193125-26-264034
SEC(opens sec.gov)
Jan 24
Saad Mark E0001193125-26-001181
SEC(opens sec.gov)
Sep 54
Saad Mark E0000950170-25-113311
SEC(opens sec.gov)
Jun 104
Saad Mark E0000950170-25-084555
SEC(opens sec.gov)
Feb 254
Saad Mark E0000950170-25-027076
SEC(opens sec.gov)
Sep 114
Saad Mark E0000950170-24-105616
SEC(opens sec.gov)
Jun 114
Saad Mark E0000950170-24-071961
SEC(opens sec.gov)
Feb 294
Saad Mark E0000950170-24-023374
SEC(opens sec.gov)

Companies

Address

C/O AXSOME THERAPEUTICS, INC. ONE WORLD TRADE CENTER, 29TH FLOOR

NEW YORK, NY, 10007